NEW YORK (Reuters) - A federal judge ruled Tuesday that a securities fraud lawsuit brought by shareholders against Pfizer Inc (nyse: PFE - news - people ) and some of its former executives can go forward, but she threw out part of the claim against Read More

Nearly four years after Merck & Co. yanked the painkiller Vioxx off the market, beleaguered pharmaceutical-industry executives say they are facing a tough new regulatory climate that is altering the landscape of drug development. Over the past 16 Read More

NEW YORK -(Dow Jones)- A federal judge said Tuesday that she will allow some securities-fraud claims to proceed against Pfizer Inc. (PFE) in a shareholder lawsuit over alleged misstatements and omissions about painkillers Celebrex and Bextra. In an Read More

‘It was both the best-performing fund in the Portfolio and the best-performing fund in our universe-by a wide margin,’ said Dion in his weekly commentary, ‘we are going to stand by this position and continue to hold Gold in the portfolio.’ In the Read More

This entry was posted on Tuesday, July 1st, 2008 at 7:33 pm and is filed under Vioxx. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.